Potential Pharmaceutical Treatments for Celiac Disease: An Interview with Joseph Murray, MD

June 10, 2013

Potential Pharmaceutical Treatments for Celiac Disease: An Interview with Joseph Murray, MD

x

Celiac disease research needs you!

Opt-in to stay up-to-date on the latest news.

Yes, I want to advance research
No, I’d prefer not to
Don’t show me this again

Joseph Murray, MD of the Mayo Clinic explains the potential pharmaceutical treatments for celiac disease.

In advance of the free June webinar, “Celiac Disease: Immunology 101 and the Drug Development Process,” the National Foundation for Celiac Awareness (NFCA) asked Joseph Murray, MD, Consultant, Division of Gastroenterology & Hepatology, Professor of Medicine,Mayo Clinic College of Medicine and NFCA Scientific/Medical Advisory Council Member to explain the potential pharmaceutical treatments currently in development for celiac disease.

Download the Q&A with Joseph Murray, MD

Register for “Celiac Disease: Immunlogy 101 and the Drug Development Process,” happening on Tuesday, June 11 at 8:30 p.m. EDT/5:30 p.m. PDT here.

OUR SPONSORS & PARTNERS